See What HealthDay Can Do For You
Contact Us

Health Highlights: July 9 2020

CDC Now Says School Reopening Guidelines Won't be Revised Higher Rates of Pain and Bleeding With Essure Birth Control Device: Study 11 Dengue Fever Cases Confirmed in Florida Keys Employers Can Refuse to Provide Birth Control Coverage: U.S Supreme Court

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

CDC Now Says School Reopening Guidelines Won't be Revised

The head of the U.S. Centers for Disease Control and Prevention now says the agency won't revise its guidelines for reopening schools despite pressure from President Donald Trump.

Instead, Dr. Robert Redfield on Thursday told ABC's "Good Morning America" that the CDC will provide additional reference documents, CNN reported.

On Twitter Wednesday morning, Trump attacked current CDC guidelines that outline preventive measures for reopening schools, and threatened to withhold funding from schools that don't fully reopen in the fall.

Trump's push to reopen schools goes against the advice of some of the nation's leading health officials and comes during a spike of coronavirus cases nationwide, CNN reported.

Later on Wednesday, Vice President Mike Pence said the CDC would issue new recommendations next week.

"Well the president said today, we just don't want the guidance to be too tough," Pence said. "That's the reason why next week, the CDC is going to be issuing a new set of tools, five different documents that will be giving even more clarity on the guidance going forward."

On Wednesday, Redfield appeared to be in step with Pence, but said Thursday that the agency wouldn't be changing any guidelines, CNN reported.

"Our guidelines are our guidelines, but we are going to provide additional reference documents to aid basically communities in trying to open K-through-12s," Redfield said. "It's not a revision of the guidelines; it's just to provide additional information to help schools be able to use the guidance we put forward."

The CDC guidelines include keeping desks six feet apart, children using cloth face coverings, the closure of communal areas like dining rooms and playgrounds, and the installation of physical barriers like sneeze guards where necessary, CNN reported.


Higher Rates of Pain and Bleeding With Essure Birth Control Device: Study

The permanent birth control device Essure is associated with higher rates of chronic lower abdominal or pelvic pain and abnormal uterine bleeding compared to tubal ligation, according to interim results of a post-market study ordered by the U.S. Food and Drug Administration.

It compared Essure and tibal ligation among more than 1,100 women across the United States and found that rates of chronic lower abdominal or pelvic pain were just over 9% in the Essure group and 4.5% in the tubal ligation group, and rates of abnormal uterine bleeding were 16.3% in the Essure group and 10.2% in the tubal ligation group, CNN reported.

The Essure group had higher rates of gynecologic operations -- including surgery to remove the device -- than the tubal ligation group, while pregnancy rates were similar in the two groups, according to a statement from Dr. Terri Cornelison, director of the FDA's Health of Women Program.

In 2018, Essure maker Bayer pulled the device from the U.S. market due to concerns about side effects. The FDA told Bayer to extend a post-market surveillance study on Essure from three to five years, CNN reported.

The study is ongoing, and patients are still completing one-year follow-up visits, the FDA said.

"Final analyses of endpoints will not be completed until the study concludes' in 2025. It is therefore too early to draw any conclusions," Bayer said in a statement, CNN reported.

"The results of several large, real-world observational studies comparing patients with Essure to patients who have had tubal ligations consistently show that Essure's safety profile is similar to that of tubal ligation," Bayer said.


11 Dengue Fever Cases Confirmed in Florida Keys

Confirmation of an 11th case of dengue fever in the Florida Keys was announced Tuesday by state health officials.

They said all 11 cases of the mosquito-borne disease have been in Key Largo, including eight cases in the last week of June, CBS News reported.

The latest patient has received treatment and is expected to fully recover, according to Florida Keys spokeswoman Alison Kerr.

The Miami Herald said that health officials believe all 11 cases were locally acquired, CBS News reported.


Employers Can Refuse to Provide Birth Control Coverage: U.S Supreme Court

More than 70,000 U.S. women could be left without cost-free birth control after the Supreme Court upheld a Trump administration policy change that permits some employers to refuse to provide contraceptive coverage on religious or moral grounds.

Lower courts had previously blocked the administration's changes to a requirement in the Affordable Care Act, but the Supreme Court on Wednesday ruled 7-2 in favor of the administration, the Associated Press reported.

"We hold today that the Departments had the statutory authority to craft that exemption, as well as the contemporaneously issued moral exemption. We further hold that the rules promulgating these exemptions are free from procedural defects," Justice Clarence Thomas wrote for a majority of the court.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.